ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Cooper, M. M.
Right arrow Articles by Clark, R. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Cooper, M. M.
Right arrow Articles by Clark, R. E.

The Annals of Thoracic Surgery, Vol 44, 370-378, Copyright © 1987 by The Society of Thoracic Surgeons


ARTICLES

Operation for hypertrophic subaortic stenosis in the aged

MM Cooper, CL McIntosh, E Tucker and RE Clark
Surgery Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20892.

To determine if operative palliation of idiopathic hypertrophic subaortic stenosis (IHSS) is worthwhile in the elderly, hemodynamic, cardiac conduction, symptomatological, functional, and survival data were examined in 52 patients (39 women) 65 years old and older (mean age, 69 years; range, 65 to 81 years) who had a left ventricular myotomy and myectomy (LVMM) (Morrow procedure) alone or with concomitant operations. Seventy-four percent of all operative survivors underwent catheterization an average of 6 months postoperatively. The mean follow-up was 54 months (range, 5 to 120 months). The population was divided for analyses into those with coronary artery disease (CAD) (N = 11,21%) and those without (N = 41). The peak resting left ventricular outflow tract gradient was reduced from 65 +/- 16 mm Hg to 3 +/- 1 mm Hg (p less than 0.01) in the group with CAD and from 95 +/- 13 mm Hg to 17 +/- 9 mm Hg (p less than 0.001) in the group without CAD. Significant reductions in peak gradients in response to provocation also occurred in both groups. New conduction abnormalities occurred in 72% of survivors, 85% of whom showed improvement in regard to symptoms. The overall average New York Heart Association Functional Class was 3.2 +/- 0.1 preoperatively and at latest follow-up, 1.9 +/- 0.1 (p less than 0.001). The hospital mortality for LVMM alone in the absence of CAD was 8% with a 5-year actuarial survival of 75 +/- 8%. LVMM in the presence of CAD resulted in an operative mortality of 27% (N = 3); all deaths were related to an acquired ventricular septal defect.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
CirculationHome page
M. A. Fifer and G. J. Vlahakes
Management of Symptoms in Hypertrophic Cardiomyopathy
Circulation, January 22, 2008; 117(3): 429 - 439.
[Full Text] [PDF]


Home page
CirculationHome page
M. A. Fifer
Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy
Circulation, July 10, 2007; 116(2): 207 - 216.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura
The case for surgery in obstructive hypertrophic cardiomyopathy
J. Am. Coll. Cardiol., November 16, 2004; 44(10): 2044 - 2053.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
Ann. Thorac. Surg., February 1, 2003; 75(2): 620 - 632.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
J. Xin, T. Shiota, H. M. Lever, S. R. Kapadia, M. Sitges, D. N. Rubin, F. Bauer, N. L. Greenberg, D. A. Agler, J. K. Drinko, et al.
Outcome of patients with hypertrophic obstructive cardiomyopathy after percutaneous transluminal septal myocardial ablation and septal myectomy surgery
J. Am. Coll. Cardiol., December 1, 2001; 38(7): 1994 - 2000.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
N. M. Lakkis, S. F. Nagueh, N. S. Kleiman, D. Killip, Z.-X. He, M. S. Verani, R. Roberts, and W. H. Spencer III
Echocardiography-Guided Ethanol Septal Reduction for Hypertrophic Obstructive Cardiomyopathy
Circulation, October 27, 1998; 98(17): 1750 - 1755.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron
The Management of Hypertrophic Cardiomyopathy
N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785.
[Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. C. Robbins and E. B. Stinson
LONG-TERM RESULTS OF LEFT VENTRICULAR MYOTOMY AND MYECTOMY FOR OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
J. Thorac. Cardiovasc. Surg., March 1, 1996; 111(3): 586 - 594.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1987 by The Society of Thoracic Surgeons.